Community-acquired hypokalemia in elderly patients: related factors and clinical outcomes

Int Urol Nephrol. 2017 Mar;49(3):483-489. doi: 10.1007/s11255-016-1489-3. Epub 2016 Dec 29.

Abstract

Purpose: Electrolyte imbalance is a common problem affecting the elderly. Increased number of comorbidities and frequent use of drugs may contribute to increased risk of hypokalemia in the elderly. This study was performed to investigate the prevalence of community-acquired hypokalemia (CAH), risk factors for its development, related factors with hypokalemia, and morbidities and all-cause mortality rates (MR) of CAH in the elderly patients.

Methods: Total of 36,361 patients aged above 65 years were screened retrospectively. Group 1 consisted of 269 elderly patients with potassium level ≤3.5 mmol/L, and group 2 (control group) consisted of 182 subjects with potassium level between 3.6 and 5.5 mmol/L. Etiologic factors of CAH, presence of comorbidities, duration of hospital stay, hospital cost, and clinical outcomes were recorded.

Results: Prevalence of hypokalemia was found 3.24% in patients aged above 65 years. Duration of hospital stay, presence of ≥2 comorbid diseases, hospital cost, and MR were significantly higher in group 1 compared to group 2 (p < 0.001 for all). Loop diuretics, hydrochlorothiazides, beta agonists, inadequate oral intake, and female gender were all independent risk factors for CAH in elderly patients. Patients with ≥2 comorbid diseases were found to have greater risk of hypokalemia than the patients with <2 comorbidities.

Conclusions: Length of hospital stay, hospital cost, and MR were higher in elderly with CAH. Female gender, hydrochlorothiazides, loop diuretics, and ≥2 comorbid diseases are the leading risk factors associated with CAH in elderly.

Keywords: Elderly; Gender; Hospital cost; Hypokalemia; Prevalence.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cause of Death*
  • Comorbidity
  • Female
  • Hospital Costs
  • Humans
  • Hydrochlorothiazide / therapeutic use
  • Hypokalemia / blood
  • Hypokalemia / epidemiology*
  • Hypokalemia / therapy
  • Length of Stay
  • Male
  • Potassium / blood*
  • Prevalence
  • Retrospective Studies
  • Risk Factors
  • Sex Factors
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
  • Turkey / epidemiology

Substances

  • Sodium Potassium Chloride Symporter Inhibitors
  • Hydrochlorothiazide
  • Potassium